Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Mitochondria in SARS-CoV-2 infection: Immune interactions and molecular approaches in the Post COVID-19 condition.

Created on 29 Aug 2026

Authors

Maria Clara Barros, Felipe Gouvêa de Souza, Helenize Costalat, Catarina Torres Pinho, Karina Carvalho Marques, Matheus Epifane-de-Assunção, Giovanna C Cavalcante, Luiz Fábio Magno Falcão, Juarez A S Quaresma, Ândrea Ribeiro-Dos-Santos

Published in

Genetics and molecular biology. Volume 49Suppl 4. Issue Suppl 4. Pages e20250118. Epub Aug 28, 2026.

Abstract

Mutations in mitochondrial genes can disrupt key cellular functions and contribute to the development of various complex diseases. The pandemic of COVID-19, caused by the SARS-CoV-2 infection, has been associated as the cause of certain mitochondrial dysfunctions, including physiological and genetic due to infection processes as increased release of reactive oxygen species (ROS), formation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome, mitophagy impairment and mitochondrial apoptotic pathway. This review compiled the main interactions between SARS-CoV-2 infection and mitochondria, highlighting mainly the genetic and immunological mechanisms that contribute to the progression of the disease and how the persistence of this inflammatory and dysfunctional state can lead to cardiac, muscular and neurological sequelae, characterizing the post COVID-19 condition.

PMID:
42664469
Bibliographic data and abstract were imported from PubMed on 29 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement